Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study

M Koopman, N F Antonini, J Douma, J Wals, A H Honkoop, F L G Erdkamp, R S de Jong, C J Rodenburg, G Vreugdenhil, J M Akkermans-Vogelaar, C J A Punt

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study'. Together they form a unique fingerprint.

Medicine & Life Sciences